[DOI] [PubMed] [Google Scholar] 25.Al-Abrash A
References Ristoff E, Augustson C, Geissler J, de Rijk T, Carlsson K, Luo JL, Andersson K, Weening RS, van Zwieten R, Larsson A, Roos D: A missense mutation in the heavy subunit of gamma-glutamylcysteine synthetase gene causes hemolytic anemia
Additionally, human clinical trials highlighted that in a fraction of FMT recipients, particularly melanoma patients who earlier responded to ICI treatment but later developed ICI-resistance, FMT restored the ICI non-responsiveness (266, 267)
Meal timing: Some individuals find smaller, more frequent meals help manage GI side effects during initial titration
In times of high toxic load or when someone is focused on supporting liver markers, a 1500 mg dose may be utilized to provide the liver with the raw materials it needs to keep up with demand
However, human evidence for this combination remains highly experimental